Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

BRAF: early-phase trial registry

1 of 2 indexed BRAF trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

BRAF: 2 US clinical trials tracked, 1 recruiting.

BRAF is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Institut de Recherches Internationales Servier, running 1 of these trials.

Enrollment posture brief

Registry condition braf

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%BRAF (this)50%
Open-enrollment share among volume-matched conditions near BRAF

BRAF lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for BRAF on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. BRAF is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on BRAF records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Fitbit Sense Device
1 trials
RX Cap Device
1 trials
Sensus Smartwatch Application Other
1 trials
FOLFOX6/FOLFOX7 Drug
1 trials
S241656 Drug
1 trials
Panitumumab Drug
1 trials
Surveys Other
1 trials
FOLFIRI Drug
1 trials

US sites by state

Facility locations filed on BRAF trials. A trial with sites in several states counts in each.

Virginia 2 trials
Washington 1 trials
New York 1 trials
Missouri 1 trials
Minnesota 1 trials
Michigan 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this BRAF page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This BRAF condition card totals 2 registered trials; most-linked intervention Fitbit Sense; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.